Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PqsBC is a heterodimeric enzyme complex in the opportunistic pathogen Pseudomonas aeruginosa, composed of the PqsB and PqsC subunits [1, 3]. It belongs to the beta-ketoacyl-acyl carrier protein synthase III (FabH) family and is specifically responsible for the condensation of 2-aminobenzoylacetate (2-ABA) with octanoyl-CoA to produce 2-heptyl-4-quinolone (HHQ) [1, 2]. HHQ serves as the immediate precursor to the Pseudomonas quinolone signal (PQS), a critical autoinducer in one of the primary quorum-sensing systems used by the bacterium to regulate virulence factors such as pyocyanin, elastase, and biofilm formation [2, 5]. Due to its central role in the alkylquinolone biosynthetic pathway, PqsBC has emerged as a prominent target for anti-virulence drug development aimed at disrupting bacterial communication rather than killing the pathogen [3, 4]. Inhibiting PqsBC effectively attenuates the pathogen's ability to coordinate damage and evade the host immune system, which is of significant interest for treating chronic lung infections in cystic fibrosis patients [4, 5]. Experimental inhibitors, including the natural competitive inhibitor 2-aminoacetophenone and various synthetic benzamide-benzimidazole derivatives, have demonstrated the potential to block HHQ production and reduce virulence factor expression [1, 4].
Inhibits the condensation of 2-aminobenzoylacetate and octanoyl-CoA, thereby blocking the synthesis of the quorum-sensing signal 2-heptyl-4-quinolone (HHQ).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-ketoacyl-(acyl carrier protein) synthase III (PqsBC) (PqsBC).